Ligand profile
ZINC1600154
Virtual-screening candidate from ZINC.
Bound to: VK055_2016 — arylsulfatase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC1600154- UniProt (similar protein)
P51691- Tanimoto
- 0.591
- Target protein
- VK055_2016
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 74.6
- −1 ≤ LogP ≤ 5 2.18
- MW ≤ 500 Da 310.2
- LogP ≤ 5 2.18
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 74.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=[P@](O)(CC[P@](=O)(O)c1ccccc1)c1ccccc1O=[P@](O)(CC[P@](=O)(O)c1ccccc1)c1ccccc1
InChI=1S/C14H16O4P2/c15-19(16,13-7-3-1-4-8-13)11-12-20(17,18)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,15,16)(H,17,18)InChI=1S/C14H16O4P2/c15-19(16,13-7-3-1-4-8-13)11-12-20(17,18)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,15,16)(H,17,18)
FYLYSEXHKNLCOF-UHFFFAOYSA-NFYLYSEXHKNLCOF-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- SV7
- Homolog
- P51691
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC1600154 →
- ZINC ZINC20 ZINC1600154 →
- UniProt UniProt P51691 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC1600154”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2016.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).